Are Options Traders Bullish on ARAV?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About ARAV

Versartis, Inc. is an endocrine-focused biopharmaceutical company initially developing somavaratan, a novel, long-acting form of recombinant human growth hormone in late-stage clinical trials for the treatment of GHD in children and adults. Somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving adherence and, therefore, treatment outcomes.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ARAV is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.5 B 1.65381E+10 3,387 3387 0.0% 0 6 K 6376
IWC iShares Microcap ETF 914.3 M 9.14298E+08 1,459 1459 0.01% 0.0001 60 K 60372
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.7 B 1.7E+09 1,015 1015 0.0% 1.32198E-05 23 K 23002
WMCR Invesco Wilshire Micro-Cap ETF 21.7 M 2.17E+07 1,083 1083 0.03% 0.00032 7 K 6938

Wait, Before You Leave...